Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness

被引:20
作者
Ehnvall, A [1 ]
Sjögren, M
Zachrisson, OCG
Agren, H
机构
[1] Varberg Hosp, Res & Dev Unit, SE-43281 Varberg, Sweden
[2] Univ Gothenburg, Inst Clin Neurosci, Dept Psychiat, Gothenburg, Sweden
[3] Karolinska Inst, Huddinge Hosp, NEUROTEC, Div Psychiat, SE-14186 Stockholm, Sweden
关键词
depression; treatment-refractory affective disorder; life charting; monoamines; cerebrospinal fluid; lifetime burden of depression;
D O I
10.1016/S0165-0327(02)00011-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: We tested if duration and intensity of episodes in treatment-resistant affectively ill patients were related to cerebrospinal fluid (CSF) concentrations of monoamine metabolites. Method: In retrospective life charts were recorded every previous episode of 37 patients with severe treatment-refractory affective disorders. 'Accumulated burden of mood swings' (ABMS, sum of each episode length X episode depth) was used to estimate the accumulated illness burden. Homovanillic acid (HVA), 3-methoxy-4-hydroxyphenylglycol (MHPG), and 5-hydroxyindoleacetic acid (5-HIAA) were analyzed in CSF of all patients and compared with 27 healthy controls. Data were analyzed using multiple regression analysis. Results: CSF MHPG contributed strongly significant and positively to the ABMS. Limitations: The retrospective nature of the study. Conclusion: CSF concentrations of MHPG is positively related to ABMS over life. Thus, a specific involvement of norepinephrine in the long-term burden of affective illness is a likely reality. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:185 / 189
页数:5
相关论文
共 23 条
[1]   INTERACTING NEUROTRANSMITTER SYSTEMS - A NONEXPERIMENTAL APPROACH TO THE 5HIAA-HVA CORRELATION IN HUMAN CSF [J].
AGREN, H ;
MEFFORD, IN ;
RUDORFER, MV ;
LINNOILA, M ;
POTTER, WZ .
JOURNAL OF PSYCHIATRIC RESEARCH, 1986, 20 (03) :175-193
[2]   CSF MONOAMINE METABOLITES IN MELANCHOLIA [J].
ASBERG, M ;
BERTILSSON, L ;
MARTENSSON, B ;
SCALIATOMBA, GP ;
THOREN, P ;
TRASKMANBENDZ, L .
ACTA PSYCHIATRICA SCANDINAVICA, 1984, 69 (03) :201-219
[3]  
ASTONJONES G, 1994, CATECHOLAMINE FUNCTI, P17
[4]  
BANKI CM, 1987, AM J PSYCHIAT, V144, P873
[5]   SIGNIFICANCE OF DECREASED LUMBAR CSF LEVELS OF HVA AND 5-HIAA IN ALZHEIMERS-DISEASE [J].
BLENNOW, K ;
WALLIN, A ;
GOTTFRIES, CG ;
LEKMAN, A ;
KARLSSON, I ;
SKOOG, I ;
SVENNERHOLM, L .
NEUROBIOLOGY OF AGING, 1992, 13 (01) :107-113
[6]  
Cullinan William E., 1995, P3
[7]   Developmental traumatology Part I: Biological stress systems [J].
De Bellis, MD ;
Baum, AS ;
Birmaher, B ;
Keshavan, MS ;
Eccard, CH ;
Boring, AM ;
Jenkins, FJ ;
Ryan, ND .
BIOLOGICAL PSYCHIATRY, 1999, 45 (10) :1259-1270
[8]  
EHNVALL A, 2002, IN PRESS J AFFECT DI
[9]  
Geracioti T D Jr, 1997, Depress Anxiety, V6, P89, DOI 10.1002/(SICI)1520-6394(1997)6:3<89::AID-DA1>3.3.CO
[10]  
2-L